Cognita

Cognita

Overview

About Cognita

Simplify's Rating
Why Cognita is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Poland

Founded

2018

People at Cognita

People at Cognita who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough designation enables prioritized FDA collaboration accelerating safety and efficacy profile development
  • Internal validation shows 16%–65% enhanced detection of significant findings and 18% efficiency boost for radiologists
  • Accelerated review path may reduce time-to-clearance compared to standard AI radiology regulatory pathways

What critics are saying

  • Aidoc First Read received FDA Breakthrough Designation for four life-threatening findings, threatening market share in 6–12 months
  • Preliminary validation data limits CAUTION language creates high risk of regulatory rejection if real-world performance fails
  • Generative AI drafting entire reports challenges FDA validation frameworks, likely mandating new post-market data requirements delaying commercialization

What makes Cognita unique

  • Cognita CXR is the first radiology generative AI model with FDA Breakthrough Device Designation
  • Generative vision-language model creates comprehensive preliminary findings instead of flagging spots for review
  • Cognita leverages exclusive access to Radiology Partners network of over 4,000 radiologists for validation

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Recently Posted Jobs

Sign up to get curated job recommendations

Cognita is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →